ICON Public Limited (NASDAQ:ICLR – Get Free Report)’s share price reached a new 52-week low on Thursday after Truist Financial lowered their price target on the stock from $284.00 to $262.00.
https://www.tipranks.com/news/the-fly/icon-energy-prices-9-16m-units-at-1-31-in-upsized-public-offering Icon Energy (ICON) announced the pricing of its public ...
Domain Holdings Australia Ltd. (DHG – Research Report) received a Buy rating and a A$3.30 price target from Bell Potter analyst Michael Ardrey today. The company’s shares opened today at A$2. ...
A woman suspected of killing three members of the same family by poisoning a Christmas cake has been found dead in her prison cell in Brazil. Deise Moura dos Anjos was found without vital signs ...
For the year the […] DUBLIN, January 30, 2025--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its ...
The public has turned on Labour after Rachel Reeves’s record tax raid triggered an economic downturn, according to a new survey. Three quarters of Britons now rate the economy as “poor ...
A federal judge on Monday paused cuts that the Trump administration had made to funding for public health research, issuing a temporary restraining order that applies only in the 22 Democratic-led ...
Trust in public health in the United States has been steadily declining since the Covid-19 pandemic, and President Donald Trump and his administration face an American public that’s deeply ...
The public sector has hired an extra 600,000 staff since the pandemic but productivity has plunged, leaving taxpayers paying more for less. The size of the public sector has swelled to 6.1m ...
Emma Raducanu became visibly upset during her match at the Dubai Tennis Championships after an encounter with a "fixated" ...
Lagan Valley Island heard cries of 'shame' as the council refused to open assessment reports in Max the dog on death row.
Powerful interview reveals that Olympics hero Sir Chris lives for each day - and sees hope in the great strides in prostate cancer research, which he is personally hugely boosting ...